Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Evive Biotechnology (Shanghai) Ltd. — Rare Disease Pipeline | Kisho | Kisho
Evive Biotechnology (Shanghai) Ltd.
Other
1
Orphan Designations
0
FDA Approvals
1
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
acute graft versus host disease
recombinant human interleukin 22-human immunoglobulin Fc fusion protein
Orphan Designation
-
← Back to Companies
